Dapsone
NDC Package 49938-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dapsone is a medication used to treat a certain type of skin disorder (dermatitis herpetiformis). Marketed by Jacobus Pharmaceutical Company, Inc., this product is identified by NDC 49938-101 and is authorized under FDA application ANDA086842.

Identification & Billing

NDC Package Code
49938-101-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
49938-101
11-Digit Billing Format
49938010101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Dapsone
Dosage Form
-
Usage Information
This medication is used to treat a certain type of skin disorder (dermatitis herpetiformis). It is also used with other drugs to treat Hansen's disease. Dapsone belongs to a class of drugs known as sulfones. It works by decreasing swelling (inflammation) and stopping the growth of bacteria. This medication will not work for viral infections (e.g., common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Jacobus Pharmaceutical Company, Inc.
FDA Application #
ANDA086842
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-03-1979
End Marketing Date
11-30-2023
Listing Expiration
11-30-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (49938-101). Click a package code to view its specific billing and regulatory data.

49938-101-28
2 BLISTER PACK in 1 CARTON / 14 TABLET in 1 BLISTER PACK
49938-101-30
2 BLISTER PACK in 1 CARTON / 15 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49938-101-01 identifies a specific commercial package of 100 tablet in 1 bottle of Dapsone, labeled by Jacobus Pharmaceutical Company, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Jacobus Pharmaceutical Company, Inc. on July 03, 1979. The current certification is valid through November 30, 2023.

What are the primary indications for this medication?

This medication is used to treat a certain type of skin disorder (dermatitis herpetiformis). It is also used with other drugs to treat Hansen's disease. Dapsone belongs to a class of drugs known as sulfones. It works by decreasing swelling (inflammation) and stopping the growth of bacteria. This medication will not work for viral infections (e.g., common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

How is this Jacobus Pharmaceutical Company, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49938010101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49938-101-01
11-Digit CMS (5-4-2)
49938-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.